$PRFX
PRF Technologies Ltd.
Nasdaq · Healthcare · Pharmaceutical Preparations · Tel Aviv
PRFX chart
What traders are saying about $PRFX
Latest postsPRF Technologies Ltd. news
- PRF Technologies Highlights $11 Million Cash, Phase 2 OcuRing™-K Trial Plans and GridFeed AI Data Center Strategy
The Globe and Mail ·
- PRF Technologies Latest Results: Cash at $11.0 million, operating loss $3.7 million
scanx.trade ·
- PRF Technologies Ltd. Estimates – NASDAQ:PRFX
TradingView ·
- PRF Technologies reports $11M cash, plans phase 2 trial
Investing.com ·
- PRF Technologies reports $11M cash, starts Phas...
Pluang ·
- PRF Technologies (PRFX) reports limited initial GridFeed revenue and about $11M in preliminary, unaudited cash.
Stock Titan ·
- PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing™-K and GridFeed™ Opportunity in AI Data Center Power
Yahoo Finance ·
- Press Release: PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing(TM)-K and GridFeed(TM) Opportunity in AI Data Center Power
Moomoo ·
- PRF Technologies’ GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power Optimization
Yahoo Finance ·
- PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform
Yahoo Finance ·
- PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business
Yahoo Finance ·
- PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy Platforms
Yahoo Finance ·
PRF Technologies Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $17,000 | $0 | $0 | – |
| Net income | -$5.0M | -$14.6M | -$9.3M | -$8.8M |
| Diluted EPS | $-7.47 | $-105.52 | $-122.94 | $-63.46 |
| Total assets (year end) | $12.0M | $4.5M | $9.9M | $12.3M |
| Cash and equivalents (year end) | $3.1M | $4.3M | $8.0M | $4.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About PRF Technologies Ltd.
- Ticker
- PRFX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1801834
- Former names
- PAINREFORM LTD.
Frequently asked questions
What exchange is PRF Technologies Ltd. listed on?
PRF Technologies Ltd. trades on the Nasdaq under the ticker symbol PRFX.
What industry is PRF Technologies Ltd. in?
PRF Technologies Ltd. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is PRF Technologies Ltd. headquartered?
PRF Technologies Ltd.'s business address on file with the SEC is in Tel Aviv.
When does PRF Technologies Ltd.'s fiscal year end?
PRF Technologies Ltd.'s fiscal year ends on December 31.
How much revenue did PRF Technologies Ltd. report?
PRF Technologies Ltd. reported $17,000 in revenue for calendar year 2025, according to its SEC filings.